Liabilities and Equity of Co-Diagnostics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Co-Diagnostics, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $44,740,761, a 38% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $44,740,761 -$27,640,410 -38% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $46,465,833 -$34,235,635 -42% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $55,149,342 -$31,521,791 -36% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $63,999,919 -$31,320,741 -33% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $72,381,171 -$36,300,564 -33% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $80,701,468 -$32,099,718 -28% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $86,671,133 -$30,325,713 -26% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $95,320,660 -$27,765,621 -23% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $108,681,735 -$39,159,376 -26% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $112,801,186 -$48,039,957 -30% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $116,996,846 -$54,154,999 -32% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $123,086,281 -$36,948,001 -23% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $147,841,111 +$42,482,503 +40% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $160,841,143 +$68,051,682 +73% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $171,151,845 +$90,032,874 +111% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $160,034,282 +$88,797,085 +125% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $105,358,608 +$50,708,108 +93% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $92,789,461 +$53,997,957 +139% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $81,118,971 +$60,638,630 +296% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $71,237,197 +$69,021,871 +3116% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $54,650,500 +$50,838,621 +1334% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $38,791,504 +$33,473,619 +629% 30 Jun 2020 10-Q/A 03 Nov 2020 2020 Q2
Q1 2020 $20,480,341 +$14,358,998 +235% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $2,215,326 +$662,154 +43% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $3,811,879 +$1,098,484 +40% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $5,317,885 +$3,348,442 +170% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $6,121,343 +$2,794,255 +84% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $1,553,172 -$3,109,154 -67% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $2,713,395 -$3,338,776 -55% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $1,969,443 +$1,501,863 +321% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 $3,327,088 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 $4,662,326 +$3,366,499 +260% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $6,052,171 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $467,580 30 Jun 2017 10-Q 25 Aug 2017 2017 Q2
Q4 2016 $1,295,827 31 Dec 2016 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.